![](/images/general/no_picture/200_user.png)
Carl D Friedman
Examiner (ID: 6600)
Most Active Art Unit | 3504 |
Art Unit(s) | 2403, 2407, 3635, 3621, 3505, 3632, 3504 |
Total Applications | 1006 |
Issued Applications | 891 |
Pending Applications | 6 |
Abandoned Applications | 109 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17775089
[patent_doc_number] => 20220241438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING GUT FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/652037
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17652037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/652037 | COMPOSITIONS AND METHODS FOR ASSESSING GUT FUNCTION | Feb 21, 2022 | Pending |
Array
(
[id] => 18536167
[patent_doc_number] => 20230241255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => MAGNETIC RESONANCE CONTRAST AGENTS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/588458
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588458 | MAGNETIC RESONANCE CONTRAST AGENTS AND METHODS THEREOF | Jan 30, 2022 | Pending |
Array
(
[id] => 17519359
[patent_doc_number] => 20220105207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer
[patent_app_type] => utility
[patent_app_number] => 17/552984
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552984 | Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer | Dec 15, 2021 | Abandoned |
Array
(
[id] => 18365876
[patent_doc_number] => 20230147467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Novel Contrast Agents and Imaging Methods for Early Detection of Diseases
[patent_app_type] => utility
[patent_app_number] => 17/523911
[patent_app_country] => US
[patent_app_date] => 2021-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17523911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/523911 | Novel Contrast Agents and Imaging Methods for Early Detection of Diseases | Nov 10, 2021 | Abandoned |
Array
(
[id] => 17719161
[patent_doc_number] => 20220211880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => IMAGING WITH LIPOSOME-BASED CONTRAST AGENTS BASED ON MODULATION OF MEMBRANE WATER PERMEABILITY
[patent_app_type] => utility
[patent_app_number] => 17/520133
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/520133 | IMAGING WITH LIPOSOME-BASED CONTRAST AGENTS BASED ON MODULATION OF MEMBRANE WATER PERMEABILITY | Nov 4, 2021 | Pending |
Array
(
[id] => 18700125
[patent_doc_number] => 11786613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Magnetic tracer compositions
[patent_app_type] => utility
[patent_app_number] => 17/497119
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 20632
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497119 | Magnetic tracer compositions | Oct 7, 2021 | Issued |
Array
(
[id] => 17368393
[patent_doc_number] => 20220023445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/403058
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17403058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/403058 | TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION | Aug 15, 2021 | Pending |
Array
(
[id] => 17503562
[patent_doc_number] => 20220096664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS
[patent_app_type] => utility
[patent_app_number] => 17/369727
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/369727 | STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS | Jul 6, 2021 | Pending |
Array
(
[id] => 17369852
[patent_doc_number] => 20220024904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => REAGENT FOR BIOCONJUGATION VIA IRREVERSIBLE REBRIDGING OF DISULFIDE LINKAGES
[patent_app_type] => utility
[patent_app_number] => 17/368272
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368272 | REAGENT FOR BIOCONJUGATION VIA IRREVERSIBLE REBRIDGING OF DISULFIDE LINKAGES | Jul 5, 2021 | Abandoned |
Array
(
[id] => 17291033
[patent_doc_number] => 20210386872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => TARGETED GAS-FILLED MICROVESICLES FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/352773
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17352773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/352773 | TARGETED GAS-FILLED MICROVESICLES FORMULATION | Jun 20, 2021 | Pending |
Array
(
[id] => 17958719
[patent_doc_number] => 20220339299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => VEGETABLE OIL-DERIVED CONTRAST AGENT WITH HIGH STABILITY AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/319912
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319912 | VEGETABLE OIL-DERIVED CONTRAST AGENT WITH HIGH STABILITY AND PREPARATION METHOD THEREOF | May 12, 2021 | Pending |
Array
(
[id] => 17214372
[patent_doc_number] => 20210347709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => RADIOFLUORINATED GPC3-BINDING PEPTIDES FOR PET IMAGING OF HEPATOCELLULAR CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/245938
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245938
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245938 | RADIOFLUORINATED GPC3-BINDING PEPTIDES FOR PET IMAGING OF HEPATOCELLULAR CARCINOMA | Apr 29, 2021 | Abandoned |
Array
(
[id] => 17005504
[patent_doc_number] => 20210236665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => BI-DOTA COMPLEX-LOADED DENDRITIC POLYMER NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/234323
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234323 | BI-DOTA COMPLEX-LOADED DENDRITIC POLYMER NANOPARTICLES | Apr 18, 2021 | Pending |
Array
(
[id] => 17273010
[patent_doc_number] => 20210379208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => MOLECULAR SENSORS WITH MODIFIED LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/224492
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17224492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/224492 | MOLECULAR SENSORS WITH MODIFIED LIGANDS | Apr 6, 2021 | Pending |
Array
(
[id] => 18517668
[patent_doc_number] => 11707539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto
[patent_app_type] => utility
[patent_app_number] => 17/211481
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28624
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17211481
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/211481 | FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto | Mar 23, 2021 | Issued |
Array
(
[id] => 18427674
[patent_doc_number] => 11672875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Nanoparticle-alginate gels for X-ray imaging of the vasculature
[patent_app_type] => utility
[patent_app_number] => 17/204524
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 3618
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204524 | Nanoparticle-alginate gels for X-ray imaging of the vasculature | Mar 16, 2021 | Issued |
Array
(
[id] => 17034942
[patent_doc_number] => 20210251900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMPOSITIONS AND METHODS FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/196036
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17196036
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/196036 | COMPOSITIONS AND METHODS FOR DRUG DELIVERY | Mar 8, 2021 | Pending |
Array
(
[id] => 16930766
[patent_doc_number] => 20210196655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => COMPOSITION FOR CROSS TALK BETWEEN ESTROGEN RECEPTORS AND CANNABINOID RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/191713
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191713
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191713 | COMPOSITION FOR CROSS TALK BETWEEN ESTROGEN RECEPTORS AND CANNABINOID RECEPTORS | Mar 3, 2021 | Pending |
Array
(
[id] => 16853591
[patent_doc_number] => 20210154336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => PLATINUM SULFIDE PROTEIN NANOPARTICLE HAVING NEAR-INFRARED PHOTOTHERMAL EFFECT AND MULTI-MODAL IMAGING FUNCTION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/169455
[patent_app_country] => US
[patent_app_date] => 2021-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169455 | Platinum sulfide protein nanoparticle having near-infrared photothermal effect and multimodal imaging function, preparation method therefor and application thereof | Feb 5, 2021 | Issued |
Array
(
[id] => 17088684
[patent_doc_number] => 11116854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Targeted contrast agents for MRI of amyloid deposition
[patent_app_type] => utility
[patent_app_number] => 17/162126
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6941
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162126
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162126 | Targeted contrast agents for MRI of amyloid deposition | Jan 28, 2021 | Issued |